Sale!

HSD17B4 Gene D-Bifunctional Protein Deficiency NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The HSD17B4 Gene D-Bifunctional Protein Deficiency NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the HSD17B4 gene responsible for D-bifunctional protein deficiency, a rare peroxisomal disorder affecting multiple body systems. This comprehensive test utilizes next-generation sequencing technology to detect pathogenic variants that disrupt essential metabolic processes, leading to severe neurological and developmental complications. The test is crucial for individuals presenting with unexplained developmental delays, seizures, hearing or vision loss, and facial dysmorphism. Early diagnosis through this $500 USD test enables targeted medical management, genetic counseling, and informed family planning decisions. Results are typically available within 3-4 weeks from blood or DNA samples collected at our nationwide testing centers.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

HSD17B4 Gene D-Bifunctional Protein Deficiency NGS Genetic DNA Test

Comprehensive Genetic Analysis for Peroxisomal Disorders

The HSD17B4 Gene D-Bifunctional Protein Deficiency NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare inherited metabolic conditions. This advanced genetic screening utilizes next-generation sequencing technology to identify mutations in the HSD17B4 gene, which encodes the D-bifunctional protein—a crucial enzyme complex essential for peroxisomal beta-oxidation of fatty acids. When this protein malfunctions due to genetic mutations, it leads to severe metabolic disruptions affecting neurological development, vision, hearing, and overall physical growth.

What This Test Measures and Detects

Our comprehensive NGS genetic test specifically targets the HSD17B4 gene located on chromosome 5q23.1, analyzing all coding regions and splice sites to identify pathogenic variants including:

  • Missense, nonsense, and frameshift mutations
  • Splice site alterations affecting protein function
  • Small insertions and deletions disrupting enzyme activity
  • Compound heterozygous mutations causing autosomal recessive inheritance

The test provides definitive diagnosis by detecting mutations that impair the three enzymatic activities of D-bifunctional protein: enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and sterol carrier protein function.

Who Should Consider This Genetic Test

Clinical Indications and Symptoms

This test is recommended for individuals presenting with symptoms suggestive of peroxisomal disorders, particularly:

  • Infants and children with unexplained developmental delays or regression
  • Patients exhibiting neonatal hypotonia progressing to hypertonia
  • Individuals with seizures that are difficult to control with standard medications
  • Children showing facial dysmorphism including high forehead, broad nasal bridge
  • Patients with sensorineural hearing loss or vision impairment
  • Individuals with hepatomegaly or liver dysfunction of unknown origin
  • Those with abnormal brain MRI findings including white matter changes
  • Family history of similar neurological or metabolic conditions

Significant Benefits of Early Genetic Testing

Undergoing the HSD17B4 genetic test provides numerous advantages for patients and families:

  • Definitive Diagnosis: Eliminates diagnostic uncertainty and enables targeted treatment approaches
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates prompt initiation of supportive therapies and management strategies
  • Prognostic Information: Helps healthcare providers anticipate disease progression and complications
  • Research Contribution: Advances understanding of rare peroxisomal disorders for future treatments

Understanding Your Test Results

Our comprehensive genetic report provides clear interpretation of your results with clinical context:

  • Positive Result: Identification of pathogenic mutations confirms D-bifunctional protein deficiency diagnosis, enabling immediate implementation of specialized care protocols
  • Negative Result: No detected mutations in HSD17B4 gene, suggesting alternative diagnoses should be considered
  • Variant of Uncertain Significance: Rare genetic changes requiring additional family studies for proper interpretation
  • Carrier Status: Identification of single mutation carriers with 25% risk of affected offspring in partner carriers

All results include detailed genetic counseling recommendations and follow-up testing options.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, and Philadelphia. Our state-of-the-art laboratories ensure consistent, reliable results regardless of collection location.

Take Action for Genetic Clarity

Don’t let diagnostic uncertainty delay proper care. Our specialized genetic testing team is ready to assist you with comprehensive HSD17B4 gene analysis and personalized genetic counseling. Early diagnosis can significantly impact treatment outcomes and quality of life for individuals with peroxisomal disorders.

Schedule your genetic consultation today by calling our dedicated genetics hotline at +1(267) 388-9828 or book your test online through our secure patient portal.

Our genetic counselors are available to discuss pre-test requirements, including the importance of providing detailed clinical history and participating in genetic counseling sessions to create comprehensive family pedigree charts for optimal test interpretation.